These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24069370)

  • 1. Insulin-like growth factor binding protein-2 level is increased in blood of lung cancer patients and associated with poor survival.
    Guo C; Lu H; Gao W; Wang L; Lu K; Wu S; Pataer A; Huang M; El-Zein R; Lin T; Roth JA; Mehran R; Hofstetter W; Swisher SG; Wu X; Fang B
    PLoS One; 2013; 8(9):e74973. PubMed ID: 24069370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative serum levels of insulin-like growth factor-binding protein 2 predict prognosis of gastric cancer patients.
    Hur H; Yu EJ; Ham IH; Jin HJ; Lee D
    Oncotarget; 2017 Feb; 8(7):10994-11003. PubMed ID: 28036255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum IGFBP2 Level Is a New Candidate Biomarker of Severe Malnutrition in Advanced Lung Cancer.
    Dong J; Zeng Y; Zhang P; Li C; Chen Y; Li Y; Wang K
    Nutr Cancer; 2020; 72(5):858-863. PubMed ID: 32286106
    [No Abstract]   [Full Text] [Related]  

  • 4. Insulin-like growth factor binding protein-2: a new circulating indicator of pulmonary arterial hypertension severity and survival.
    Yang J; Griffiths M; Nies MK; Brandal S; Damico R; Vaidya D; Tao X; Simpson CE; Kolb TM; Mathai SC; Pauciulo MW; Nichols WC; Ivy DD; Austin ED; Hassoun PM; Everett AD
    BMC Med; 2020 Oct; 18(1):268. PubMed ID: 33019943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative plasma IGFBP2 is associated with nodal metastasis in patients with penile squamous cell carcinoma.
    Hu X; Chen M; Liu W; Li Y; Fu J
    Urol Oncol; 2019 Jul; 37(7):452-461. PubMed ID: 31053522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trichostatin A reverses the chemoresistance of lung cancer with high IGFBP2 expression through enhancing autophagy.
    Tang D; Yao R; Zhao D; Zhou L; Wu Y; Yang Y; Sun Y; Lu L; Gao W
    Sci Rep; 2018 Mar; 8(1):3917. PubMed ID: 29500455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is insulin-like growth factor binding protein 2 associated with metastasis in lung cancer?
    Hu Q; Huang L; Kuang X; Zhang H; Ling G; Chen X; Li K; Deng Z; Zhou J
    Clin Exp Metastasis; 2014 Jun; 31(5):535-41. PubMed ID: 24682597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of IGF and IGFBP as prognostic serum biomarkers for adrenocortical carcinoma.
    Patel D; Ellis R; Howard B; Boufraqech M; Gara SK; Zhang L; Quezado MM; Nilubol N; Kebebew E
    Ann Surg Oncol; 2014 Oct; 21(11):3541-7. PubMed ID: 24833102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum IGFBP2 and MSLN as diagnostic and prognostic biomarkers for pancreatic cancer.
    Kendrick ZW; Firpo MA; Repko RC; Scaife CL; Adler DG; Boucher KM; Mulvihill SJ
    HPB (Oxford); 2014 Jul; 16(7):670-6. PubMed ID: 24308545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic and diagnostic value of circulating IGFBP2 in pancreatic cancer.
    Xu J; Song Y; Zhou B; Yuan S; Gao S
    Open Med (Wars); 2024; 19(1):20230893. PubMed ID: 39221034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiorenal interaction and heart failure outcomes. A role for insulin-like growth factor binding protein 2?
    Ravassa S; Beaumont J; Cediel G; Lupón J; López B; Querejeta R; Díez J; Bayés-Genís A; González A
    Rev Esp Cardiol (Engl Ed); 2020 Oct; 73(10):835-843. PubMed ID: 31948893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric pulmonary hypertension: insulin-like growth factor-binding protein 2 is a novel marker associated with disease severity and survival.
    Griffiths M; Yang J; Nies M; Vaidya D; Brandal S; Williams M; Matsui EC; Grant T; Damico R; Ivy D; Austin ED; Nichols WC; Pauciulo MW; Lutz K; Rosenzweig EB; Hirsch R; Yung D; Everett AD
    Pediatr Res; 2020 Dec; 88(6):850-856. PubMed ID: 32927467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating IGF system and treatment outcome in epithelial ovarian cancer.
    Huang YF; Cheng WF; Wu YP; Cheng YM; Hsu KF; Chou CY
    Endocr Relat Cancer; 2014 Apr; 21(2):217-29. PubMed ID: 24273235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of serum insulin-like growth factor-binding protein 2 for ovarian cancer.
    Prayudi PKA; Budiana ING; Mahayasa PD; Surya IGNHW; Wiradnyana AAGP; Suwiyoga K
    Int J Gynecol Cancer; 2020 Nov; 30(11):1762-1767. PubMed ID: 32817171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
    Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ
    Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum insulin-like growth factor binding protein 2 levels as biomarker for pancreatic ductal adenocarcinoma-associated malnutrition and muscle wasting.
    Dong J; Yu J; Li Z; Gao S; Wang H; Yang S; Wu L; Lan C; Zhao T; Gao C; Liu Z; Wang X; Hao J
    J Cachexia Sarcopenia Muscle; 2021 Jun; 12(3):704-716. PubMed ID: 33763996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies against insulin-like growth factor‑binding protein-2 as a serological biomarker in the diagnosis of lung cancer.
    Zhang Y; Ying X; Han S; Wang J; Zhou X; Bai E; Zhang J; Zhu Q
    Int J Oncol; 2013 Jan; 42(1):93-100. PubMed ID: 23165420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of IGFBP2 mRNA predicts poor survival in patients with glioblastoma.
    Yuan Q; Cai HQ; Zhong Y; Zhang MJ; Cheng ZJ; Hao JJ; Wang MR; Wan JH
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31138764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients.
    Köhler J; Schuler M; Gauler TC; Nöpel-Dünnebacke S; Ahrens M; Hoffmann AC; Kasper S; Nensa F; Gomez B; Hahnemann M; Breitenbuecher F; Cheufou D; Özkan F; Darwiche K; Hoiczyk M; Reis H; Welter S; Eberhardt WE; Eisenacher M; Teschler H; Stamatis G; Schmiegel W; Hahn SA; Baraniskin A
    J Cancer Res Clin Oncol; 2016 Apr; 142(4):795-805. PubMed ID: 26687686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like Growth Factor Binding Protein 2 predicts mortality risk in heart failure.
    Barutaut M; Fournier P; Peacock WF; Evaristi MF; Caubère C; Turkieh A; Desmoulin F; Eurlings LWM; van Wijk S; Rocca HB; Butler J; Koukoui F; Dambrin C; Mazeres S; Le Page S; Delmas C; Galinier M; Jung C; Smih F; Rouet P
    Int J Cardiol; 2020 Feb; 300():245-251. PubMed ID: 31806281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.